Colin Hislop, Chief Medical Officer at Anthera Pharmaceuticals Inc (ANTH), sold 5,000 shares at $5.38 ($27K) on 2015-11-11, disclosed to the SEC on 2015-11-12.
Open-market sale of $27k ANTH by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ANTH | SELL | 2015-11-18 | $66K | — | Filing → |
| ANTH | SELL | 2012-02-06 | $246K | — | Filing → |
| ANTH | SELL | 2011-11-10 | $101K | — | Filing → |